跳至主要内容
临床试验/NCT00690768
NCT00690768已完成2 期

Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV for Diabetic Tractional Retinal Detachment (IBETRA Study)

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
1
主要终点
amount of intraoperative intra-ocular bleeding

研究概览

简要总结

The purpose of this study is to compare the amount of intraoperative intraocular bleeding during 23-gauge pars plana vitrectomy (PPV) for diabetic traction retinal detachment (TRD) with and without preoperative intravitreal bevacizumab treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Macular traction retinal detachment lasting three months or less secondary to diabetic retinopathy.

排除标准

  • Massive vitreous hemorrhage preventing from detailed posterior pole examination;
  • Previous intra-ocular surgery other than cataract surgery
  • Hemodialysis, known bleeding disorders or use of anticoagulants drugs other than aspirin
  • Prothrombin time, partial thromboplastin time or platelet count without normal limits
  • History of previous thromboembolic events

研究组 & 干预措施

A

Experimental

Preoperative Intravitreal bevacizumab and pars plana vitrectomy

干预措施: Bevacizumab (Drug)

A

Experimental

Preoperative Intravitreal bevacizumab and pars plana vitrectomy

干预措施: pars plana vitrectomy (Procedure)

B

Active Comparator

Pars plana vitrectomy only

干预措施: pars plana vitrectomy (Procedure)

结局指标

主要结局

amount of intraoperative intra-ocular bleeding

时间窗: three weeks

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验